InsidersTradesSigma
Discover the detailed record of transactions filed by Clowes Howard, Director. Director active across 1 companies, notably Plus Therapeutics, INC.. Aggregated, 1 disclosures have been recorded. Total volume traded: €8k. The latest transaction was filed on 2 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Howard Clowes is a Board Member at PLUS THERAPEUTICS, INC. He brings expertise in business management and growth strategies. His role as a board member involves overseeing the company's operations and contributing to strategic decision-making. Howard is committed to ensuring compliance and promoting best governance practices within the organization.